Inicure AB
Developing novel small molecules to combat resistant bacterial infections effectively.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 2024
- Founded
Key Decision Makers
Peter Olofsson-Sahl
CEO
Johan Bylund
CSO and Professor of Microbiology
Sara Malcus
Chairman and Business Development
Description
Inicure AB is a biotechnology company spun off from Pronoxis AB, established in 2024. The core mission of the organization is to combat the growing global threat of antibiotic resistance. They specialize in developing novel anti-infectious assets based on activating the formyl peptide receptor-1 (FP...